Insider · CIK 0001760431

Reardon Tighe

Reports to the SEC for 2 companies · LA JOLLA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001760431

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-03	JANXJanux Therapeutics, Inc.S Sale	Acting Chief Financial Officer	SSale	−131K sh	$54.75	−$7.18M	633,673
2024-06-03	JANXJanux Therapeutics, Inc.S Sale	Acting Chief Financial Officer	SSale	−692K sh	$54.75	−$37.9M	3,340,018
2024-01-02	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Acting Chief Financial Officer	AAward	+157K sh	—	—	157,000
2023-11-13	JANXJanux Therapeutics, Inc.P Purchase	Acting Chief Financial Officer	PPurchase	+850K sh	$5.87	+$4.99M	849,854
2023-01-03	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Acting Chief Financial Officer	AAward	+110K sh	—	—	110,000
2022-01-03	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Acting Chief Financial Officer	AAward	+117K sh	—	—	116,750
2021-06-15	JANXJanux Therapeutics, Inc.C Conversion	Acting Chief Financial Officer	CConversion	+2.7M sh	—	—	2,696,843
2021-06-15	JANXJanux Therapeutics, Inc.C Conversion	Acting Chief Financial Officer	CConversion	+1.15M sh	—	—	3,850,081
2021-06-15	JANXJanux Therapeutics, Inc.P Purchase	Acting Chief Financial Officer	PPurchase	+629K sh	$17.00	+$10.7M	4,479,492
2021-06-15	JANXJanux Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Acting Chief Financial Officer	CConversion	−2.11M sh	—	—	0
2021-06-15	JANXJanux Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion	Acting Chief Financial Officer	CConversion	−900K sh	—	—	0
2020-01-23	Synthorx, Inc.U Disposition from Tender	Acting Chief Financial Officer	UDisposition from Tender	−43.7K sh	$68.00	−$2.97M	0
2020-01-23	Synthorx, Inc.U Disposition from Tender	Acting Chief Financial Officer	UDisposition from Tender	−1.68M sh	$68.00	−$114M	0
2020-01-23	Synthorx, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Acting Chief Financial Officer	DDisposition to Issuer	−18.7K sh	$63.36	−$1.19M	0
2020-01-23	Synthorx, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Acting Chief Financial Officer	DDisposition to Issuer	−30K sh	$57.00	−$1.71M	0
2018-12-11	Synthorx, Inc.C Conversion	Acting Chief Financial Officer	CConversion	+1.14M sh	—	—	1,136,631
2018-12-11	Synthorx, Inc.P Purchase	Acting Chief Financial Officer	PPurchase	+545K sh	$11.00	+$6M	1,682,086
2018-12-11	Synthorx, Inc.Series C Preferred StockC Conversion	Acting Chief Financial Officer	CConversion	−1.82M sh	—	—	0
2018-12-06	Synthorx, Inc.Employee Stock Option (right to buy)A Award	Acting Chief Financial Officer	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Jun 54
Reardon Tighe0001415889-24-015676
SEC(opens sec.gov)
Jan 34
Reardon Tighe0001209191-24-000435
SEC(opens sec.gov)
Nov 154
Reardon Tighe0001209191-23-055352
SEC(opens sec.gov)
Jan 54
Reardon Tighe0001209191-23-001882
SEC(opens sec.gov)
Jan 54
Reardon Tighe0001209191-22-001830
SEC(opens sec.gov)
Jun 164
Reardon Tighe0001209191-21-041041
SEC(opens sec.gov)
Jan 244
Reardon Tighe0001209191-20-004927
SEC(opens sec.gov)
Dec 134
Reardon Tighe0001209191-18-062518
SEC(opens sec.gov)
Dec 74
Reardon Tighe0001209191-18-061570
SEC(opens sec.gov)

Companies

Address

C/O SYNTHORX, INC. 11099 N. TORREY PINES ROAD, SUITE 190

LA JOLLA, CA, 92037